Prices are updated after-hours

Biora Therapeutics Inc

BIOR | $0.609 1.59% 12K

(0.0% 1d) (-48.7% 1m) (-76.3% 1y) (0.0% 2d) (0.0% 3d) (0.2% 7d) (-46.07% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 21,853,260
https://www.progenity.com
Sec Filling | Patents | 642 employees

(US) Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

treatment diagnostics

add to watch list Paper trade email alert is off